Natural Products: Therapeutic Properties and Beyond II

Detalhes bibliográficos
Autor(a) principal: Duarte, Ana Paula
Data de Publicação: 2022
Outros Autores: Luís, Ângelo, Gallardo, Eugenia
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.6/12546
Resumo: Historically, natural products have contributed to drug discovery as a source of active molecules due to their great diversity and structural complexity. Thus, they have contributed to the development of drugs for applications in different therapeutic areas. In recent decades, there has been a paradigm shift in drug discovery strategies that has allowed for identifying new natural products that exhibit activities on therapeutic targets. Newman and Cragg studied the origin of 1330 new drugs that had been approved between 1981 and 2010 and found that 64% of them were somewhat related to natural compounds [1]. In a recent review by these same authors, it was noted that, within all of the drugs newly approved by the Food and Drug Administration between January 1981 and September 2019, compounds derived from natural products ranked second [2]. Besides the importance of the discovery of new molecules based on natural compounds, the concern today is focused on the therapeutic potential of secondary metabolites classified as drugs of abuse, such as derivatives of cannabis [3] and psilocybin [4], or even on the use of plants used ancestrally in medicine as well [5,6]. On the other hand, with the development of computational techniques, a decision has been made to study the possibilities of analyzing the pharmacological potential of natural products or their derivatives and converting these molecules into low toxicity active products. However, apart from the use of naturally occurring compounds in the field of health, they have been studied and are increasingly used in solutions, for instance in the agrochemical and food industries. After the success of the Special Issue “Natural Products: Therapeutic Properties and Beyond I”, this second edition aims to categorize the state of the art concerning scientific research on natural products, including their applications as compounds with added value to human health. This issue intends to be used as a text for academia or as a reference tool for researchers, particularly for those working in the fields of medicinal chemistry, toxicology, phytochemistry, and natural product chemistry, and for health and industry professionals.
id RCAP_248c2e439dc481899fec808d83870bd2
oai_identifier_str oai:ubibliorum.ubi.pt:10400.6/12546
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Natural Products: Therapeutic Properties and Beyond IINatural ProductsHistorically, natural products have contributed to drug discovery as a source of active molecules due to their great diversity and structural complexity. Thus, they have contributed to the development of drugs for applications in different therapeutic areas. In recent decades, there has been a paradigm shift in drug discovery strategies that has allowed for identifying new natural products that exhibit activities on therapeutic targets. Newman and Cragg studied the origin of 1330 new drugs that had been approved between 1981 and 2010 and found that 64% of them were somewhat related to natural compounds [1]. In a recent review by these same authors, it was noted that, within all of the drugs newly approved by the Food and Drug Administration between January 1981 and September 2019, compounds derived from natural products ranked second [2]. Besides the importance of the discovery of new molecules based on natural compounds, the concern today is focused on the therapeutic potential of secondary metabolites classified as drugs of abuse, such as derivatives of cannabis [3] and psilocybin [4], or even on the use of plants used ancestrally in medicine as well [5,6]. On the other hand, with the development of computational techniques, a decision has been made to study the possibilities of analyzing the pharmacological potential of natural products or their derivatives and converting these molecules into low toxicity active products. However, apart from the use of naturally occurring compounds in the field of health, they have been studied and are increasingly used in solutions, for instance in the agrochemical and food industries. After the success of the Special Issue “Natural Products: Therapeutic Properties and Beyond I”, this second edition aims to categorize the state of the art concerning scientific research on natural products, including their applications as compounds with added value to human health. This issue intends to be used as a text for academia or as a reference tool for researchers, particularly for those working in the fields of medicinal chemistry, toxicology, phytochemistry, and natural product chemistry, and for health and industry professionals.uBibliorumDuarte, Ana PaulaLuís, ÂngeloGallardo, Eugenia2023-01-02T11:00:46Z20222022-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.6/12546eng10.3390/molecules27196140info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-12-15T09:55:46Zoai:ubibliorum.ubi.pt:10400.6/12546Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T00:52:07.779420Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Natural Products: Therapeutic Properties and Beyond II
title Natural Products: Therapeutic Properties and Beyond II
spellingShingle Natural Products: Therapeutic Properties and Beyond II
Duarte, Ana Paula
Natural Products
title_short Natural Products: Therapeutic Properties and Beyond II
title_full Natural Products: Therapeutic Properties and Beyond II
title_fullStr Natural Products: Therapeutic Properties and Beyond II
title_full_unstemmed Natural Products: Therapeutic Properties and Beyond II
title_sort Natural Products: Therapeutic Properties and Beyond II
author Duarte, Ana Paula
author_facet Duarte, Ana Paula
Luís, Ângelo
Gallardo, Eugenia
author_role author
author2 Luís, Ângelo
Gallardo, Eugenia
author2_role author
author
dc.contributor.none.fl_str_mv uBibliorum
dc.contributor.author.fl_str_mv Duarte, Ana Paula
Luís, Ângelo
Gallardo, Eugenia
dc.subject.por.fl_str_mv Natural Products
topic Natural Products
description Historically, natural products have contributed to drug discovery as a source of active molecules due to their great diversity and structural complexity. Thus, they have contributed to the development of drugs for applications in different therapeutic areas. In recent decades, there has been a paradigm shift in drug discovery strategies that has allowed for identifying new natural products that exhibit activities on therapeutic targets. Newman and Cragg studied the origin of 1330 new drugs that had been approved between 1981 and 2010 and found that 64% of them were somewhat related to natural compounds [1]. In a recent review by these same authors, it was noted that, within all of the drugs newly approved by the Food and Drug Administration between January 1981 and September 2019, compounds derived from natural products ranked second [2]. Besides the importance of the discovery of new molecules based on natural compounds, the concern today is focused on the therapeutic potential of secondary metabolites classified as drugs of abuse, such as derivatives of cannabis [3] and psilocybin [4], or even on the use of plants used ancestrally in medicine as well [5,6]. On the other hand, with the development of computational techniques, a decision has been made to study the possibilities of analyzing the pharmacological potential of natural products or their derivatives and converting these molecules into low toxicity active products. However, apart from the use of naturally occurring compounds in the field of health, they have been studied and are increasingly used in solutions, for instance in the agrochemical and food industries. After the success of the Special Issue “Natural Products: Therapeutic Properties and Beyond I”, this second edition aims to categorize the state of the art concerning scientific research on natural products, including their applications as compounds with added value to human health. This issue intends to be used as a text for academia or as a reference tool for researchers, particularly for those working in the fields of medicinal chemistry, toxicology, phytochemistry, and natural product chemistry, and for health and industry professionals.
publishDate 2022
dc.date.none.fl_str_mv 2022
2022-01-01T00:00:00Z
2023-01-02T11:00:46Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.6/12546
url http://hdl.handle.net/10400.6/12546
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.3390/molecules27196140
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799136410600472576